Nets: The missing link between cell death and systemic autoimmune diseases?

Frontiers in Immunology

Volumn 3, Issue JAN, 2012, Pages

  Darrah, Erika ^a   Andrade, Felipe ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Autoimmune disease; Cell death; Necrosis; Netosis; Nets

Indexed keywords

EID: 84874284576     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00428     Document Type: Article

References (192)

1. Al-Mayouf, S. M., Sunker, A., Abd-wani, R., Abrawi, S. A., Almurshedi, F., Alhashmi, N., et al. (2011). Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nat. Genet. 43, 1186-1188.
2. Alfaro, C., Suarez, N., Onate, C., Perez-Gracia, J. L., Martinez-Forero, I., Hervas-Stubbs, S., et al. (2011). Dendritic cells take up and present antigens from viable and apoptotic polymorphonuclear leukocytes. PLoS ONE 6:e29300. doi: 10.1371/jour-nal.pone.0029300
3. Andrade, F., Casciola-Rosen, L., and Rosen, A. (2000). Apoptosis in systemic lupus erythematosus. Clinical implications. Rheum. Dis. Clin. North Am. 26, 215-227, v.
4. Andrade, F., Casciola-Rosen, L. A., and Rosen, A. (2005). Generation of novel covalent RNA-protein complexes in cells by ultraviolet B irradiation: implications for autoimmunity. Arthritis Rheum. 52, 1160-1170.
5. Bave, U., Alm, G. V., and Ronnblom, L. (2000). The combination of apop-totic U937 cells and lupus IgG is a potent IFN-alpha inducer. J. Immunol. 165, 3519-3526.
6. Bave, U., Magnusson, M., Eloranta, M. L., Perers, A., Alm, G. V., and Ronnblom, L. (2003). Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG. J. Immunol. 171, 3296-3302.
7. Bave, U., Vallin, H., Alm, G. V., and Ronnblom, L. (2001). Activation of natural interferon-alpha producing cells by apoptotic U937 cells combined with lupus IgG and its regulation by cytokines. J. Autoimmun. 17, 71-80.
8. Bell, D. A., and Morrison, B. (1991). The spontaneous apoptotic cell death of normal human lymphocytes in vitro: the release of, and immunoprolifera-tive response to, nucleosomes in vitro. Clin. Immunol. Immunopathol. 60, 13-26.
9. Bell, D. A., Morrison, B., and Van-denBygaart, P. (1990). Immunogenic DNA-related factors nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes. J. Clin. Invest. 85, 1487-1496.
10. Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., et al. (2003). Interferon and granu-lopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197, 711-723.
11. Bernard, J. J., Cowing-Zitron, C., Nakat-suji, T., Muehleisen, B., Muto, J., Borkowski, A. W., et al. (2012). Ultraviolet radiation damages self noncod-ing RNA and is detected by TLR3. Nat. Med. 1286-1290.
12. Bickerstaff, M. C., Botto, M., Hutchin-son, W. L., Herbert, J., Tennent, G. A., Bybee, A., et al. (1999). Serum amyloid P component controls chromatin degradation and prevents antinu-clear autoimmunity. Nat. Med. 5, 694-697.
13. Bogdan, C., Mattner, J., and Schleicher, U. (2004). The role of type I interfer-ons in non-viral infections. Immunol. Rev. 202, 33-48.
14. Bottcher, A., Gaipl, U. S., Furn-rohr, B. G., Herrmann, M., Girkon-taite, I., Kalden, J. R., et al. (2006). Involvement of phosphatidylserine, alphavbeta3, CD14, CD36, and complement C1q in the phagocytosis of primary necrotic lymphocytes by macrophages. Arthritis Rheum. 54, 927-938.
15. Botto, M., Dell'Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., et al. (1998). Homozy-gous C1q deficiency causes glomeru-lonephritis associated with multiple apoptotic bodies. Nat. Genet. 19, 56-59.
16. Breathnach, S. M., Kofler, H., Sepp, N., Ashworth, J., Woodrow, D., Pepys, M. B., et al. (1989). Serum amyloid P component binds to cell nuclei in vitro and to in vivo deposits of extracellular chromatin in systemic lupus erythematosus. J. Exp. Med. 170, 1433-1438.
17. Brichory, F. M., Misek, D. E., Yim, A. M., Krause, M. C., Giordano, T. J., Beer, D. G., et al. (2001). An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc. Natl. Acad. Sci. U.S.A. 98, 9824-9829.
18. Brinkmann, V., Reichard, U., Goos-mann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., et al. (2004). Neutrophil extracellular traps kill bacteria. Science 303, 1532-1535.
19. Brouckaert, G., Kalai, M., Krysko, D. V., Saelens, X., Vercammen, D., Ndlovu, M. N., et al. (2004). Phagocytosis of necrotic cells by macrophages is phosphatidylserine dependent and does not induce inflammatory cytokine production. Mol. Biol. Cell 15, 1089-1100.
20. Burnet, F. M. (1959). The Clonal Selection Theory of Acquired Immunity. Nashville, Vanderbilt University Press.
21. Buse, C., Altmann, F., Amann, B., Hauck, S. M., Poulsen, N. C., Ueffing, M., et al. (2008). Discovering novel targets for autoantibodies in dilated cardiomyopathy. Electrophoresis 29, 1325-1332.
22. Butler, P. J. G., Tennent, G. A., and Pepys, M. B. (1990). Pentraxin-chromatin interactions: serum amyloid P component specifically displaces H1-type histones and solubilizes native long chromatin. J. Exp. Med. 172, 13-18.
23. Bygrave, A. E., Rose, K. L., Cortes-Hernandez, J., Warren, J., Rigby, R. J., Cook, H. T., et al. (2004). Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol. 2:e243. doi: 10.1371/journal.pbio.0020243
24. Campbell, A. M., Kashgarian, M., and Shlomchik, M. J. (2012). NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus. Sci. Transl. Med. 4, 157ra141.
25. Caproni, M., Torchia, D., Cardinali, C., Volpi, W., Del, B. E., D'Agata, A., et al. (2004). Infiltrating cells, related cytokines and chemokine receptors in lesional skin of patients with der-matomyositis. Br. J. Dermatol. 151, 784-791.
26. Carlson, J. A., and Chen, K. R. (2006). Cutaneous vasculitis update: small vessel neutrophilic vasculitis syndromes. Am. J. Dermatopathol. 28, 486-506.
27. Carlucci, F., Cortes-Hernandez, J., Fossati-Jimack, L., Bygrave, A. E., Walport, M. J., Vyse, T. J., et al. (2007). Genetic dissection of spontaneous autoimmunity driven by 129-derived chromosome 1 loci when expressed on C57BL/6 mice. J. Immunol. 178, 2352-2360.
28. Carretero, M., Escamez, M. J., Garcia, M., Duarte, B., Holguin, A., Reta-mosa, L., et al. (2008). In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37. J. Invest. Dermatol. 128, 223-236.
29. Carroll, M. C. (2004). A protective role for innate immunity in systemic lupus erythematosus. Nat. Rev. Immunol. 4, 825-831.
30. Carroll, M. C., and Isenman, D. E. (2012). Regulation of humoral immunity by complement. Immunity 37, 199-207.
31. Cartwright, G. E., Athens, J. W., and Wintrobe, M. M. (1964). The kinetics of granulopoiesis in normal man. Blood 24, 780-803.
32. Casares, N., Pequignot, M. O., Tes-niere, A., Ghiringhelli, F., Roux, S., Chaput, N., et al. (2005). Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J. Exp. Med. 202, 1691-1701.
33. Casciola-Rosen, L., Andrade, F., Ulanet, D., Wong, W. B., and Rosen, A. (1999). Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J. Exp. Med. 190, 815-825.
34. Casciola-Rosen, L. A., Anhalt, G., and Rosen, A. (1994). Autoantigens targeted in systemic lupus erythemato-sus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179, 1317- 1330.
35. Chen, Z., Koralov, S. B., and Kelsoe, G. (2000). Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J. Exp. Med. 192, 1339-1352.
36. Clayton, A. R., Prue, R. L., Harper, L., Drayson, M. T., and Savage, C. O. (2003). Dendritic cell uptake of human apoptotic and necrotic neu-trophils inhibits CD40, CD80, and CD86 expression and reduces allo-geneic T cell responses: relevance to systemic vasculitis. Arthritis Rheum. 48, 2362-2374.
37. Cohen, P. L., Caricchio, R., Abraham, V., Camenisch, T. D., Jennette, J. C., Roubey, R. A., et al. (2002). Delayed apoptotic cell clearance and lupuslike autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J. Exp. Med. 196, 135-140.
38. Cooper, G. S., Bynum, M. L., and Somers, E. C. (2009). Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J. Autoimmun. 33, 197-207.
39. Courtney, P. A., Crockard, A. D., Williamson, K., Irvine, A. E., Kennedy, R. J., and Bell, A. L. (1999). Increased apoptotic peripheral blood neutrophils in systemic lupus erythe-matosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann. Rheum. Dis. 58, 309-314.
40. Darrah, E., and Rosen, A. (2010). Granzyme B cleavage of autoantigens in autoimmunity. Cell Death Differ. 17, 624-632.
41. Darrah, E., Rosen, A., Giles, J. T., and Andrade, F. (2012). Peptidy-larginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis. Ann. Rheum. Dis. 71, 92-98.
42. Davies, D. J., Moran, J. E., Niall, J. F., and Ryan, G. B. (1982). Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br. Med. J. (Clin. Res. Ed.) 285, 606.
43. Davis, J. C., Jr., Manzi, S., Yarboro, C., Rairie, J., Mcinnes, I., Averthelyi, D., et al. (1999). Recombinant human DNase I (rhDNase) in patients with lupus nephritis. Lupus 8, 68-76.
44. Denny, M. F., Yalavarthi, S., Zhao, W., Thacker, S. G., Anderson, M., Sandy, A. R., et al. (2010). A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J. Immunol. 184, 3284-3297.
45. Devitt, A., Parker, K. G., Ogden, C. A., Oldreive, C., Clay, M. F., Melville, L. A., et al. (2004). Persistence of apoptotic cells without autoimmune disease or inflammation in CD14-/-mice. J. Cell Biol. 167, 1161-1170.
46. Di, N. A., Braff, M. H., Taylor, K. R., Na, C., Granstein, R. D., McInturff, J. E., et al. (2007). Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization. J. Immunol. 178, 1829-1834.
47. Dieker, J. W., Fransen, J. H., van Bavel, C. C., Briand, J. P., Jacobs, C. W., Muller, S., et al. (2007). Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythe-matosus. Arthritis Rheum. 56, 1921- 1933.
48. Du Clos, T. W. (1989). C-reactive protein reacts with the U1 small nuclear ribonucleoprotein. J. Immunol. 143, 2553-2559.
49. Du Clos, T. W., Zlock, L. T., and Rubin, R. L. (1988). Analysis of the binding of C-reactive protein to his-tones and chromatin. J. Immunol. 141, 4266-4270.
50. Dwivedi, N., Upadhyay, J., Neeli, I., Khan, S., Pattanaik, D., Myers, L., et al. (2012). Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps. Arthritis Rheum. 64, 982-992.
51. Edassery, S. L., Shatavi, S. V., Kunkel, J. P., Hauer, C., Brucker, C., Penu-matsa, K., et al. (2010). Autoantigens in ovarian autoimmunity associated with unexplained infertility and premature ovarian failure. Fertil. Steril. 94, 2636-2641.
52. Emlen, W., Niebur, J., and Kadera, R. (1994). Accelerated in vitro apop-tosis of lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 152, 3685-3692.
53. Falk, R. J., and Jennette, J. C. (1988). Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomeru-lonephritis. N. Engl. J. Med. 318, 1651-1657.
54. Fernandez, D., and Perl, A. (2009). Metabolic control of T cell activation and death in SLE. Autoimmun. Rev. 8, 184-189.
55. Fernandez, D., and Perl, A. (2010). mTOR signaling: a central pathway to pathogenesis in systemic lupus ery-thematosus? Discov. Med. 9, 173-178.
56. Fesus, L., Demeny, M. A., and Petrovski, G. (2011). Autophagy shapes inflammation. Antioxid. Redox Signal. 14, 2233-2243.
57. Fuchs, T. A., Abed, U., Goosmann, C., Hurwitz, R., Schulze, I., Wahn, V., et al. (2007). Novel cell death program leads to neutrophil extracellular traps. J. Cell Biol. 176, 231-241.
58. Gaipl, U. S., Beyer, T. D., Hey-der, P., Kuenkele, S., Bottcher, A., Voll, R. E., et al. (2004). Cooperation between C1q and DNase I in the clearance of necrotic cell-derived chromatin. Arthritis Rheum. 50, 640-649.
59. Galluzzi, L., Vitale, I., Abrams, J. M., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., et al. (2012). Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committeeon Cell Death 2012. Cell Death Differ. 19, 107-120.
60. Garcia-Romo, G. S., Caielli, S., Vega, B., Connolly, J., Allantaz, F., Xu, Z., et al. (2011). Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 3, 73ra20.
61. Garg, A. D., Krysko, D. V.,Vandenabeele, P., and Agostinis, P. (2012). The emergence of phox-ER stress induced immunogenic apoptosis. Oncoim-munology 1, 786-788.
62. Geering, B., and Simon, H. U. (2011). Peculiarities of cell death mechanisms in neutrophils. Cell Death Differ. 18, 1457-1469.
63. Gergely, P., Jr., Grossman, C., Niland, B., Puskas, F., Neupane, H., Allam, F., et al. (2002). Mitochondrial hyper-polarization and ATP depletion in patients with systemic lupus ery-thematosus. Arthritis Rheum. 46, 175-190.
64. Gershov, D., Kim, S., Brot, N., and Elkon, K. B. (2000). C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J. Exp. Med. 192, 1353-1364.
65. Ghosh, S., Seward, R., Costello, C. E., Stollar, B. D., and Huber, B. T. (2006). Autoantibodies from syn-ovial lesions in chronic, antibiotic treatment-resistant Lyme arthritis bind cytokeratin-10. J. Immunol. 177, 2486-2494.
66. Gillmore, J. D., Hutchinson, W. L., Herbert, J., Bybee, A., Mitchell, D. A., Hasserjian, R. P., et al. (2004). Autoimmunity and glomeru-lonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination? Immunology 112, 255-264.
67. Gottenberg, J. E., Cagnard, N., Lucchesi, C., Letourneur, F., Mistou, S., Lazure, T., et al. (2006). Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome. Proc. Natl. Acad. Sci. U.S.A. 103, 2770- 2775.
68. Greenberg, S. A., Pinkus, J. L., Pinkus, G. S., Burleson, T., Sanoudou, D., Tawil, R., et al. (2005). Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann. Neurol. 57, 664-678.
69. Gullstrand, B., Martensson, U., Sturfelt, G., Bengtsson, A. A., and Trueds-son, L. (2009). Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells. Clin. Exp. Immunol. 156, 303-311.
70. Hacbarth, E., and Kajdacsy-Balla, A. (1986). Low density neutrophils in patients with systemic lupus ery-thematosus, rheumatoid arthritis, and acute rheumatic fever. Arthritis Rheum. 29, 1334-1342.
71. Hakkim, A.,Furnrohr,B.G.,Amann,K., Laube, B., Abed, U. A., Brinkmann, V., et al. (2010). Impairment of neu-trophil extracellular trap degradation is associated with lupus nephritis. Proc. Natl. Acad. Sci. U.S.A. 107, 9813-9818.
72. Hall, J. C., Casciola-Rosen, L., and Rosen, A. (2004). Altered structure of autoantigens during apoptosis. Rheum. Dis. Clin. North Am. 30, 455-471, vii.
73. Han, J., Zhong, C. Q., and Zhang, D. W. (2011). Programmed necrosis: backup to and competitor with apoptosis in the immune system. Nat. Immunol. 12, 1143-1149.
74. Hanayama, R., Tanaka, M., Miyasaka, K., Aozasa, K., Koike, M., Uchiyama, Y., et al. (2004). Autoimmune disease and impaired uptake of apop-totic cells in MFG-E8-deficient mice. Science 304, 1147-1150.
75. Hart, S. P., Alexander, K. M., Mac-Call, S. M., and Dransfield, I. (2005). C-reactive protein does not opsonize early apoptotic human neu-trophils, but binds only membrane-permeable late apoptotic cells and has no effect on their phagocytosis by macrophages. J. Inflamm. (Lond.) 2, 5.
76. Hayakawa, T., Jin, C. X., Ko, S. B., Kita-gawa, M., and Ishiguro, H. (2009). Lactoferrin in gastrointestinal disease. Intern. Med. 48, 1251-1254.
77. Heidari, Y., Bygrave, A. E., Rigby, R. J., Rose, K. L., Walport, M. J., Cook, H. T., et al. (2006). Identification of chromosome intervals from 129 and C57BL/6 mouse strains linked to the development of systemic lupus erythematosus. Genes Immun. 7, 592-599.
78. Heilborn, J. D., Nilsson, M. F., Kratz, G., Weber, G., Sorensen, O., Borre-gaard, N., et al. (2003). The cathe-licidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 120, 379-389.
79. Higgs, B. W., Liu, Z., White, B., Zhu, W., White, W. I., Morehouse, C., et al. (2011). Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I inter-feron pathway. Ann. Rheum. Dis. 70, 2029-2036.
80. Higgs, B. W., Zhu, W., Richman, L., Fiorentino, D. F., Greenberg, S. A., Jallal, B., et al. (2012). Identification of activated cytokine pathways in the blood of systemic lupus erythemato-sus, myositis, rheumatoid arthritis, and scleroderma patients. Int. J. Rheum. Dis. 15, 25-35.
81. Hintner, H., Booker, J., Ashworth, J., Aubock, J., Pepys, M. B., and Breath-nach, S. M. (1988). Amyloid P component binds to keratin bodies in human skin and to isolated keratin filament aggregates in vitro. J. Invest. Dermatol. 91, 22-28.
82. Hirt, U. A., Gantner, F., and Leist, M. (2000). Phagocytosis of nonapoptotic cells dying by caspase-independent mechanisms. J. Immunol. 164, 6520-6529.
83. Hirt, U. A., and Leist, M. (2003). Rapid, noninflammatory and PS-dependent phagocytic clearance of necrotic cells. Cell Death Differ. 10, 1156-1164.
84. Hjelmervik, T. O., Petersen, K., Jonassen, I., Jonsson, R., and Bolstad, A. I. (2005). Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy control subjects. Arthritis Rheum. 52, 1534-1544.
85. Holdenrieder, S., Eichhorn, P., Beuers, U., Samtleben, W., Schoenermarck, U., Zachoval, R., et al. (2006). Nucle-osomal DNA fragments in autoimmune diseases. Ann. N. Y. Acad. Sci. 1075, 318-327.
86. Iaccarino, L., Ghirardello, A., Canova, M., Zen, M., Bettio, S., Nalotto, L., et al. (2011). Anti-annexins autoan-tibodies: their role as biomarkers of autoimmune diseases. Autoimmun. Rev. 10, 553-558.
87. Jewell, W. S., Marnell, L. L., Rokeach, L. A., and Du Clos, T. W. (1993). C-reactive protein (CRP) binding to the Sm-D protein of snRNPs. Identification of a short polypeptide binding region. Mol. Immunol. 30, 701-708.
88. Johansson, U., Walther-Jallow, L., Hof-mann, A., and Spetz, A. L. (2011). Dendritic cells are able to produce IL-12p70 after uptake of apoptotic cells. Immunobiology 216, 251-255.
89. Kaiser, W. J., Upton, J. W., Long, A. B., Livingston-Rosanoff, D., Daley-Bauer, L. P., Hakem, R., et al. (2011). RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471, 368-372.
90. Kennedy, A. D., and DeLeo, F. R. (2009). Neutrophil apoptosis and the resolution of infection. Immunol. Res. 43, 25-61.
91. Kerr, J. F. R., Wyllie, A. H., and Currie, A. R. (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257.
92. Kessenbrock, K., Krumbholz, M., Schonermarck, U., Back, W., Gross, W. L., Werb, Z., et al. (2009). Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 15, 623-625.
93. Knight, J. S., and Kaplan, M. J. (2012). Lupus neutrophils: 'NET' gain in understanding lupus pathogenesis. Curr. Opin. Rheumatol. 24, 441-450.
94. Kolln, J., Ren, H. M., Da, R. R., Zhang, Y., Spillner, E., Olek, M., et al. (2006). Triosephos-phate isomerase and glyceraldehyde-3-phosphate dehydrogenase-reactive autoantibodies in the cerebrospinal fluid of patients with multiple sclerosis. J. Immunol. 177, 5652-5658.
95. Krysko, D. V., D'Herde, K., and Van-denabeele, P. (2006). Clearance of apoptotic and necrotic cells and its immunological consequences. Apop-tosis 11, 1709-1726.
96. Lachmann, P. J. (2003). Lupus and des-oxyribonuclease. Lupus 12, 202-206.
97. Lai, Y., and Gallo, R. L. (2009). AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 30, 131-141.
98. Lamour, A., Le, C. R., Pennec, Y. L., Cartron, J., and Youinou, P. (1995). Heterogeneity of neutrophil antibodies in patients with primary Sjogren's syndrome. Blood 86, 3553-3559.
99. Lande, R., Ganguly, D., Facchinetti, V., Frasca, L., Conrad, C., Gre-gorio, J., et al. (2011). Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythemato-sus. Sci. Transl. Med. 3, 73ra19.
100. Lang, F., and Qadri, S. M. (2012). Mechanisms and significance of eryptosis, the suicidal death of erythrocytes. Blood Purif. 33, 125-130.
101. Lau, C. M., Broughton, C., Tabor, A. S., Akira, S., Flavell, R. A., Mamula, M. J., et al. (2005). RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med. 202, 1171-1177.
102. Le, B. A., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D., et al. (2003). Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat. Immunol. 4, 1009-1015.
103. Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., and Marshak-Rothstein, A. (2002). Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416, 603-607.
104. Leffler, J., Martin, M., Gullstrand, B., Tyden, H., Lood, C., Truedsson, L., et al. (2012). Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J. Immunol. 188, 3522-3531.
105. Li, M., Carpio, D. F., Zheng, Y., Bruzzo, P., Singh, V., Ouaaz, F., et al. (2001). An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J. Immunol. 166, 7128- 7135.
106. Li, P., Li, M., Lindberg, M. R., Ken-nett, M. J., Xiong, N., and Wang, Y. (2010). PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J. Exp. Med. 207, 1853-1862.
107. Lin, J. H., Dutz, J. P., Sontheimer, R. D., and Werth, V. P. (2007). Pathophysiology of cutaneous lupus erythematosus. Clin. Rev. Allergy Immunol. 33, 85-106.
108. Lin, M. L., Zhan, Y., Villadangos, J. A., and Lew, A. M. (2008). The cell biology of cross-presentation and the role of dendritic cell subsets. Immunol. Cell Biol. 86, 353-362.
109. Lindh, E., Brannstrom, J., Jones, P., Wermeling, F., Hassler, S., Betterle, C, et al. (2012). Autoimmunity and cystatin SA1 deficiency behind chronic mucocutaneous candidiasis in autoimmune polyendocrine syndrome type 1. J. Autoimmun. doi: 10.1016/j.jaut.2012.10.001 [Epub ahead of print].
110. Liu, C. L., Tangsombatvisit, S., Rosenberg, J. M., Mandelbaum, G., Gillespie, E. C., Gozani, O. P., et al. (2012). Specific post-translational histone modifications of neutrophil extracellular traps as immunogens and potential targets of lupus autoantibodies. Arthritis Res. Ther. 14, R25.
111. Lovato, L., Cianti, R., Gini, B., Marconi, S., Bianchi, L., Armini, A., et al. (2008). Transketolase and 2/,3/-cyclic-nucleotide 3;-phosphodie-sterase type I isoforms are specifically recognized by IgG autoantibodies in multiple sclerosis patients. Mol. Cell. Proteomics 7, 2337-2349.
112. Lovgren, T., Eloranta, M. L., Bave, U., Alm, G. V., and Ronnblom, L. (2004). Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. ArthritisRheum. 50,1861-1872.
113. Lu, J. V., and Walsh, C. M. (2012). Programmed necrosis and autophagy in immune function. Immunol. Rev. 249,205-217.
114. Ludemann, J., Utecht, B., and Gross, W. L. (1990). Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme.J. Exp. Med. 171, 357-362.
115. Mahoney, W. M., Jr., Fleming, J. N., and Schwartz, S. M. (2011). A unifying hypothesis for scleroderma: identifying atarget cell for scleroderma. Curr. Rheumatol. Rep. 13,28-36.
116. Maianski, N. A., Geissler, J., Sriniva-sula, S. M., Alnemri, E. S., Roos, D., and Kuijpers, T. W (2004). Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis. Cell Death Differ. 11, 143-153.
117. Makino, H., Sugiyama, H., Yamasaki, Y., Maeshima, Y., Wada, J., and Kashihara, N. (2003). Glomerular cell apoptosis in human lupus nephritis. Virchows Arch. 443, 67-77.
118. Manderson, A. P., Botto, M., and Walport, M. J. (2004). The role of complement in the development of systemic lupus erythematosus. Annu. Rev. Immunol. 22, 431-456.
119. Manolova, I., Dancheva, M., and Halacheva, K. (2001). Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations. Rheumatol. Int. 20, 197-204.
120. Mansour, R. B., Lassoued, S., Gar-gouri, B., El, G. A., Attia, H., and Fakhfakh, F. (2008). Increased levels of autoantibodies against cata-lase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus. Scand. J. Rheumatol. 37, 103-108.
121. Margraf, S., Logters, T., Reipen, J., Altrichter, J., Scholz, M., and Windolf, J. (2008). Neutrophil-derived circulating free DNA (cf-DNA/NETs): a potential prognostic marker for post-traumatic development of inflammatory second hit and sepsis. Shock 30, 352-358.
122. Marshak-Rothstein, A., and Rifkin, I. R. (2007). Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu. Rev. Immunol. 25, 419-441.
123. Martinelli, S., Urosevic, M., Daryadel, A., Oberholzer, P. A., Baumann, C., Fey, M. F., et al. (2004). Induction of genes mediating interferon-dependent extracellular trap formation during neutrophil differentiation. J. Biol. Chem. 279, 44123-44132.
124. Martinez, V. F., Balada, E., Ordi-Ros, J., and Vilardell-Tarres, M. (2008). DNase 1 and systemic lupus ery-thematosus. Autoimmun. Rev. 7, 359-363.
125. Mason, K. D., Carpinelli, M. R., Fletcher, J. I., Collinge, J. E., Hilton, A. A., Ellis, S., et al. (2007). Programmed anu-clear cell death delimits platelet life span. Cell 128, 1173-1186.
126. Miao, E. A., Leaf, I. A., Treuting, P. M., Mao, D. P., Dors, M., Sarkar, A., et al. (2010). Caspase-1-induced pyropto-sis is an innate immune effector mechanism against intracellular bacteria. Nat. Immunol. 11, 1136-1142.
127. Midgley, A., McLaren, Z., Moots, R. J., Edwards, S. W., and Beresford, M. W. (2009). The role of neutrophil apop-tosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum. 60, 2390-2401.
128. Mihalache, C. C., Yousefi, S., Conus, S., Villiger, P. M., Schneider, E. M., and Simon, H. U. (2011). Inflammation-associated autophagy-related programmed necrotic death of human neutrophils characterized by organelle fusion events. J. Immunol. 186, 6532-6542.
129. Miles, K., Clarke, D. J., Lu, W., Sibin-ska, Z., Beaumont, P. E., Davidson, D. J., et al. (2009). Dying and necrotic neutrophils are anti-inflammatory secondary to the release of alpha-defensins. J. Immunol. 183, 2122-2132.
130. Mitchell, D. A., Pickering, M. C., Warren, J., Fossati-Jimack, L., Cortes-Hernandez, J., Cook, H. T., et al. (2002). C1q deficiency and autoim-munity: the effects of genetic background on disease expression. J. Immunol. 168, 2538-2543.
131. Mitchell, D. A., Taylor, P. R., Cook, H. T., Moss, J., Bygrave, A. E., Wal-port, M. J., et al. (1999). Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation. J. Immunol. 162, 5676-5679.
132. Mocarski, E. S., Upton, J. W., and Kaiser, W. J. (2012). Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways. Nat. Rev. Immunol. 12, 79-88.
133. Mohr, W., Westerhellweg, H., and Wess-inghage, D. (1981). Polymorphonu-clear granulocytes in rheumatic tissue destruction. III. An electron microscopic study of PMNs at the pannus-cartilage junction in rheumatoid arthritis. Ann. Rheum. Dis. 40, 396-399.
134. Molad, Y., Buyon, J., Anderson, D. C., Abramson, S. B., and Cronstein, B. N. (1994). Intravascular neutrophil activation in systemic lupus ery-thematosus (SLE): dissociation between increased expression of CD11b/CD18 and diminished expression of L-selectin on neutrophils from patients with active SLE. Clin. Immunol. Immunopathol. 71, 281-286.
135. Mulder, A. H., Horst, G., van Leeuwen, M. A., Limburg, P. C., and Kallen-berg, C. G. (1993). Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Characterization and clinical correlations. Arthritis Rheum. 36, 1054-1060.
136. Munoz, L. E., Lauber, K., Schiller, M., Manfredi, A. A., and Herrmann, M. (2010). The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat. Rev. Rheumatol. 6, 280-289.
137. Nagaoka, I., Hirota, S., Niyonsaba, F., Hirata, M., Adachi, Y., Tamura, H., et al. (2001). Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells. J. Immunol. 167, 3329-3338.
138. Napirei, M., Gultekin, A., Kloeckl, T., Moroy, T., Frostegard, J., and Mannherz, H. G. (2006). Systemic lupus-erythematosus: deoxyribonu-clease 1 in necrotic chromatin disposal. Int. J. Biochem. Cell Biol. 38, 297-306.
139. Napirei, M., Karsunky, H., Zevnik, B., Stephan, H., Mannherz, H. G., and Moroy, T. (2000). Features of systemic lupus erythematosus in DNase1-deficient mice. Nat. Genet. 25, 177-181.
140. Napirei, M., Wulf, S., and Mannherz, H. G. (2004). Chromatin breakdown during necrosis by serum DNase1 and the plasminogen system. Arthritis Rheum. 50, 1873-1883.
141. Nathan, C. (2006). Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6, 173-182.
142. Neeli, I., Khan, S. N., and Radic, M. (2008). Histone deimination as a response to inflammatory stimuli in neutrophils. J. Immunol. 180, 1895-1902.
143. Oberst, A., Dillon, C. P., Weinlich, R., McCormick, L. L., Fitzgerald, P., Pop, C., et al. (2011). Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471, 363-367.
144. Paul, E., Pozdnyakova, O. O., Mitchell, E., and Carroll, M. C. (2002). Anti-DNA autoreactivity in C4-deficient mice. Eur. J. Immunol. 32, 2672-2679.
145. Petrovski, G., Berenyi, E., Moe, M. C., Vajas, A., Fesus, L., Berta, A., et al. (2011). Clearance of dying ARPE-19 cells by professional and nonprofessional phagocytes in vitro-implications for age-related macular degeneration (AMD). Acta Ophthal-mol. 89, e30-e34.
146. Petrovski, G., Zahuczky, G., Katona, K., Vereb, G., Martinet, W., Nemes, Z., et al. (2007). Clearance of dying autophagic cells of different origin by professional and non-professional phagocytes. Cell Death Differ. 14, 1117-1128.
147. Petrovski, G., Zahuczky, G., Majai, G., and Fesus, L. (2007). Phagocytosis of cells dying through autophagy evokes a pro-inflammatory response in macrophages. Autophagy 3, 509-511.
148. Ravichandran, K. S. (2011). Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways. Immunity 35, 445-455.
149. Remijsen, Q., Kuijpers, T. W., Wirawan, E., Lippens, S., Vandenabeele, P., and Vanden Berghe, T. (2011). Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality. Cell Death Differ. 18, 581-588.
150. Ren, Y., Stuart, L., Lindberg, F. P., Rosenkranz, A. R., Chen,Y., Mayadas, T. N., et al. (2001). Nonphlogis-tic clearance of late apoptotic neu-trophils by macrophages: efficient phagocytosis independent of beta 2 integrins. J. Immunol. 166, 4743-4750.
151. Renaudineau, Y., Deocharan, B., Jousse, S., Renaudineau, E., Putterman, C., and Youinou, P. (2007). Anti-alpha-actinin antibodies: a new marker of lupus nephritis. Autoimmun. Rev. 6, 464-468.
152. Rock, K. L., Lai, J. J., and Kono, H. (2011). Innate and adaptive immune responses to cell death. Immunol. Rev. 243, 191-205.
153. Ronnblom, L., Alm, G. V., and Eloranta, M. L. (2011). The type I interferon system in the development of lupus. Semin. Immunol. 23, 113-121.
154. Rumore, P. M., and Steinman, C. R. (1990). Endogenous circulating DNA in systemic lupus erythemato-sus. Occurrence as multimeric complexes bound to histone. J. Clin. Invest. 86, 69-74.
155. Rutjes, S. A., Utz, P. J., van der, H. A., Broekhuis, C., van Venrooij, W. J., and Pruijn, G. J. (1999). The La (SS-B) autoantigen, a key protein in RNA biogenesis, is dephosphorylated and cleaved early during apoptosis. Cell Death Differ. 6, 976-986.
156. Saffarzadeh, M., Juenemann, C., Queisser, M. A., Lochnit, G., Barreto, G., Galuska, S. P., et al. (2012). Neu-trophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of his-tones. PLoS ONE 7:e32366. doi: 10.1371/journal.pone.0032366
157. Schiller, M., Parcina, M., Heyder, P., Foermer, S., Ostrop, J., Leo, A., et al. (2012). Induction of type I IFN is a physiological immune reaction to apoptotic cell-derived membrane microparticles. J. Immunol. 189, 1747-1756.
158. Schultz, D. R., and Tozman, E. C. (1995). Antineutrophil cytoplas-mic antibodies: major autoantigens, pathophysiology, and disease associations. Semin. Arthritis Rheum. 25, 143-159.
159. Schwentker, F. F., and Rivers, T. M. (1934). The antibody response of rabbits to injections of emulsion and extracts of homologous brain. J. Exp. Med. 60, 559-574.
160. Shen, G. Q., Shoenfeld,Y., and Peter, J. B. (1998). Anti-DNA, antihistone, and antinucleosome antibodies in systemic lupus erythematosus and drug-induced lupus. Clin. Rev. Allergy Immunol. 16, 321-334.
161. Silva, M. T. (2010). Secondary necrosis: the natural outcome of the complete apoptotic program. FEBS Lett. 584, 4491-4499.
162. Sokolove, J., Bromberg, R., Deane, K. D., Lahey, L. J., Derber, L. A., Chandra, P. E., et al. (2012). Autoan-tibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS ONE 7:e35296. doi: 10.1371/jour-nal.pone.0035296
163. Sokolove, J., Zhao, X., Chandra, P. E., and Robinson, W. H. (2011). Immune complexes containing citrullinated fibrinogen costimu-late macrophages via Toll-like receptor 4 and Fcgamma receptor. Arthritis Rheum. 63, 53-62.
164. Stuart, L. M., Takahashi, K., Shi, L., Savill, J., and Ezekowitz, R. A. (2005). Mannose-binding lectin-deficient mice display defective apop-totic cell clearance but no autoimmune phenotype. J. Immunol. 174, 3220-3226.
165. Suber, T. L., Casciola-Rosen, L., and Rosen, A. (2008). Mechanisms of disease: autoantigens as clues to the pathogenesis of myositis. Nat. Clin. Pract. Rheumatol. 4, 201-209.
166. Takasaki, Y., Kaneda, K., Matsushita, M., Yamada, H., Nawata, M., Mat-sudaira, R., et al. (2004). Glyc-eraldehyde 3-phosphate dehydroge-nase is a novel autoantigen leading autoimmune responses to proliferating cell nuclear antigen multipro-tein complexes in lupus patients. Int. Immunol. 16, 1295-1304.
167. Trouw, L. A., Nilsson, S. C., Goncalves, I., Landberg, G., and Blom, A. M. (2005). C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation. J. Exp. Med. 201, 1937-1948.
168. Ueda, K., Nakanishi, T., Shimizu, A., Takubo, T., and Matsuura, N. (2008). Identification of L-plastin autoan-tibody in plasma of patients with non-Hodgkin's lymphoma using a proteomics-based analysis. Ann. Clin. Biochem. 45, 65-69.
169. Urban, C. F., Ermert, D., Schmid, M., Abu-Abed, U., Goosmann, C., Nacken, W., et al. (2009). Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog. 5:e1000639. doi: 10.1371/journal.ppat.1000639
170. Urbonaviciute, V., Furnrohr, B. G., Meister, S., Munoz, L., Heyder, P., De, M. F., et al. (2008). Induction of inflammatoryand immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J. Exp. Med. 205, 3007- 3018.
171. Utz, P. J., Gensler, T. J., and Anderson, P. (2000). Death, autoantigen modifications, and tolerance. Arthritis Res. 2, 101-114.
172. Utz, P. J., Hottelet, M., Schur, P. H., and Anderson, P. (1997). Proteins phos-phorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J. Exp. Med. 185, 843-854.
173. van Bavel, C. C., Dieker, J. W., Kroeze, Y., Tamboer, W. P., Voll, R., Muller, S., et al. (2011). Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus. Ann. Rheum. Dis. 70, 201-207.
174. van Rossum, A. P., Limburg, P. C., and Kallenberg, C. G. (2005). Activation, apoptosis, and clearance of neutrophils in Wegener's granulo-matosis. Ann. N. Y. Acad. Sci. 1051, 1-11.
175. van, B. L., Cossu, M., and Radstake, T. R. (2011). An update on an immune system that goes awry in systemic sclerosis. Curr. Opin. Rheumatol. 23, 505-510.
176. van der Vaart M, and Pretorius, P. J. (2008). Circulating DNA. Its origin and fluctuation. Ann. N. Y. Acad. Sci. 1137, 18-26.
177. Villanueva, E., Yalavarthi, S., Berthier, C. C., Hodgin, J. B., Khandpur, R., Lin, A. M., et al. (2011). Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J. Immunol. 187, 538-552.
178. Volanakis, J. E., and Wirtz, K. W. A. (1979). Interaction of C-reactive protein with artificial phos-phatidylcholine bilayers. Nature 281, 155-157.
179. Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., and Girkon-taite, I. (1997). Immunosuppressive effects of apoptotic cells. Nature 390, 350-351.
180. Vollmer, J., Tluk, S., Schmitz, C., Hamm, S., Jurk, M., Forsbach, A., et al. (2005). Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J. Exp. Med. 202, 1575-1585.
181. von, G. S., and Simon, H. U. (2007). Autophagic-like cell death in neu-trophils induced by autoantibodies. Autophagy 3, 67-68.
182. Walsh, R. J., Kong, S. W., Yao, Y., Jallal, B., Kiener, P. A., Pinkus, J. L., et al. (2007). Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyosi-tis. Arthritis Rheum. 56, 3784-3792.
183. Wegner, N., Lundberg, K., Kinloch, A., Fisher, B., Malmstrom, V., Feld-mann, M., et al. (2010). Autoimmu-nity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol. Rev. 233, 34-54.
184. Wickman, G., Julian, L., and Olson, M. F. (2012). How apoptotic cells aid in the removal of their own cold dead bodies. Cell Death Differ. 19, 735-742.
185. Wu, W., Liu, P., and Li, J. (2012). Necroptosis: an emerging form of programmed cell death. Crit. Rev. Oncol. Hematol. 82, 249-258.
186. Yasutomo, K., Horiuchi, T., Kagami, S., Tsukamoto, H., Hashimura, C., Urushihara, M., et al. (2001). Mutation of DNASE1 in people with systemic lupus erythematosus. Nat. Genet. 28, 313-314.
187. Yipp, B. G., Petri, B., Salina, D., Jenne, C. N., Scott, B. N., Zbytnuik, L. D., et al. (2012). Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo. Nat. Med. 18, 1386-1393.
188. Yousefi, S., Mihalache, C., Kozlowski, E., Schmid, I., and Simon, H. U. (2009). Viable neutrophils release mitochon-drial DNA to form neutrophil extracellular traps. Cell Death Differ. 16, 1438-1444.
189. Yu, D., Rumore, P. M., Liu, Q., and Steinman, C. R. (1997). Soluble oligonucleosomal complexes in synovial fluid from inflamed joints. Arthritis Rheum. 40, 648-654.
190. Zhang, H., Zhou, X., McQuade, T., Li, J., Chan, F. K., and Zhang, J. (2011). Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 471, 373-376.
191. Zhao, M. H., Jones, S. J., and Lockwood, C. M. (1995). Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vas-culitis. Clin. Exp. Immunol. 99, 49-56.
192. Zoutendyk, A., and Gear, J. (1951). Auto-antibodies in the pathogene-sis of disease; a preliminary study of auto-sensitization of red cells in various diseases. S. Afr. Med. J. 25, 665-668.